| 1 | dopamine biosynthetic process (GO:0042416) | 9.18293082 |
| 2 | serotonin metabolic process (GO:0042428) | 8.75039965 |
| 3 | toxin metabolic process (GO:0009404) | 8.49246784 |
| 4 | primary amino compound metabolic process (GO:1901160) | 7.60423870 |
| 5 | indolalkylamine metabolic process (GO:0006586) | 7.28215385 |
| 6 | nephron epithelium morphogenesis (GO:0072088) | 6.22811284 |
| 7 | nephron tubule morphogenesis (GO:0072078) | 6.22811284 |
| 8 | hindbrain development (GO:0030902) | 5.91903848 |
| 9 | RNA destabilization (GO:0050779) | 5.81111815 |
| 10 | catechol-containing compound biosynthetic process (GO:0009713) | 5.41986600 |
| 11 | catecholamine biosynthetic process (GO:0042423) | 5.41986600 |
| 12 | nephron tubule formation (GO:0072079) | 5.29688869 |
| 13 | multicellular organismal aging (GO:0010259) | 5.18690150 |
| 14 | histone H3-K9 methylation (GO:0051567) | 5.17476541 |
| 15 | fatty acid elongation (GO:0030497) | 5.05819165 |
| 16 | indole-containing compound metabolic process (GO:0042430) | 4.79595210 |
| 17 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.79488818 |
| 18 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.78864674 |
| 19 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.69297527 |
| 20 | renal tubule morphogenesis (GO:0061333) | 4.65106876 |
| 21 | cellular biogenic amine biosynthetic process (GO:0042401) | 4.58789686 |
| 22 | negative regulation of metanephros development (GO:0072217) | 4.49453231 |
| 23 | amine biosynthetic process (GO:0009309) | 4.30530548 |
| 24 | intestinal epithelial cell development (GO:0060576) | 4.15146511 |
| 25 | dopamine metabolic process (GO:0042417) | 4.14239354 |
| 26 | response to UV-C (GO:0010225) | 4.04287508 |
| 27 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 4.01940482 |
| 28 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 4.01940482 |
| 29 | histone H3-K9 modification (GO:0061647) | 3.96998526 |
| 30 | basic amino acid transport (GO:0015802) | 3.92328102 |
| 31 | regulation of meiosis I (GO:0060631) | 3.91065892 |
| 32 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.86010533 |
| 33 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.76793881 |
| 34 | ATP synthesis coupled proton transport (GO:0015986) | 3.67846377 |
| 35 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.67846377 |
| 36 | cellular response to ethanol (GO:0071361) | 3.60251552 |
| 37 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.49860283 |
| 38 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.49860283 |
| 39 | vitamin transmembrane transport (GO:0035461) | 3.48573664 |
| 40 | postsynaptic membrane organization (GO:0001941) | 3.45731949 |
| 41 | cerebellar Purkinje cell layer development (GO:0021680) | 3.45612028 |
| 42 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.36134341 |
| 43 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.34017230 |
| 44 | negative regulation of kidney development (GO:0090185) | 3.33746781 |
| 45 | opioid receptor signaling pathway (GO:0038003) | 3.31300681 |
| 46 | heparin biosynthetic process (GO:0030210) | 3.28211331 |
| 47 | heparin metabolic process (GO:0030202) | 3.28211331 |
| 48 | phasic smooth muscle contraction (GO:0014821) | 3.27459788 |
| 49 | platelet dense granule organization (GO:0060155) | 3.23923652 |
| 50 | protein-cofactor linkage (GO:0018065) | 3.15686569 |
| 51 | detection of light stimulus involved in visual perception (GO:0050908) | 3.11699532 |
| 52 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.11699532 |
| 53 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.11016908 |
| 54 | iron coordination entity transport (GO:1901678) | 3.10714549 |
| 55 | transepithelial transport (GO:0070633) | 3.10483306 |
| 56 | regulation of stem cell maintenance (GO:2000036) | 3.09596212 |
| 57 | embryonic epithelial tube formation (GO:0001838) | 3.09535388 |
| 58 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.04473240 |
| 59 | cellular response to alkaloid (GO:0071312) | 3.03739909 |
| 60 | protein ADP-ribosylation (GO:0006471) | 2.99445728 |
| 61 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.95136439 |
| 62 | phenol-containing compound biosynthetic process (GO:0046189) | 2.94263588 |
| 63 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.93982919 |
| 64 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.93140580 |
| 65 | epithelial tube formation (GO:0072175) | 2.92133690 |
| 66 | lung lobe morphogenesis (GO:0060463) | 2.89783940 |
| 67 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.89707173 |
| 68 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.89681278 |
| 69 | central nervous system neuron axonogenesis (GO:0021955) | 2.89610255 |
| 70 | RNA localization (GO:0006403) | 2.89582080 |
| 71 | anterograde synaptic vesicle transport (GO:0048490) | 2.87891547 |
| 72 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.81614228 |
| 73 | regulation of mRNA catabolic process (GO:0061013) | 2.80363030 |
| 74 | keratinocyte development (GO:0003334) | 2.79343897 |
| 75 | positive regulation of actin filament depolymerization (GO:0030836) | 2.78721211 |
| 76 | histone H3-K4 trimethylation (GO:0080182) | 2.75166127 |
| 77 | peristalsis (GO:0030432) | 2.73488898 |
| 78 | protein heterotetramerization (GO:0051290) | 2.71561227 |
| 79 | positive regulation of mRNA processing (GO:0050685) | 2.69826010 |
| 80 | mRNA cleavage (GO:0006379) | 2.68951260 |
| 81 | positive regulation of T cell apoptotic process (GO:0070234) | 2.68035636 |
| 82 | catecholamine metabolic process (GO:0006584) | 2.67986834 |
| 83 | catechol-containing compound metabolic process (GO:0009712) | 2.67986834 |
| 84 | establishment of protein localization to Golgi (GO:0072600) | 2.66810272 |
| 85 | galactose metabolic process (GO:0006012) | 2.65407337 |
| 86 | positive regulation of gastrulation (GO:2000543) | 2.65252661 |
| 87 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.63403589 |
| 88 | drug transmembrane transport (GO:0006855) | 2.62881647 |
| 89 | urinary tract smooth muscle contraction (GO:0014848) | 2.61093436 |
| 90 | secondary metabolic process (GO:0019748) | 2.61001063 |
| 91 | auditory receptor cell stereocilium organization (GO:0060088) | 2.55895593 |
| 92 | presynaptic membrane organization (GO:0097090) | 2.52305494 |
| 93 | regulation of hippo signaling (GO:0035330) | 2.52205439 |
| 94 | protein targeting to Golgi (GO:0000042) | 2.50703518 |
| 95 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.50241257 |
| 96 | anterograde axon cargo transport (GO:0008089) | 2.49807722 |
| 97 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.49669392 |
| 98 | respiratory chain complex IV assembly (GO:0008535) | 2.49114820 |
| 99 | alkaloid metabolic process (GO:0009820) | 11.6992295 |
| 100 | response to insecticide (GO:0017085) | 10.0775997 |
KRT19P2 
